General Information
Version
8.0
Revision date
2024-03-14
Product name
Paricalcitol
CAS No.
131918-61-1
1.2.1 Relevant identified uses
Laboratory chemicals, Synthesis of substances
Emergency telephone
800-424-9300, +1-703- 527-3887
Icons in SDS
Company Information
company name
Sigma-Aldrich Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301+H311, H330, H372
Hazard statements
Code
Statements
H301+H311
Toxic if swallowed or in contact with skin
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Signal word
Danger
Hazard statements
H301 + H311 Toxic if swallowed or in contact with skin. H330 Fatal if inhaled. H372 Causes damage to organs through prolonged or repeated exposure if swallowed.
Precautionary statements
P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P271 Use only outdoors or in a well-ventilated area. P280 Wear protective gloves/ protective clothing. P284 Wear respiratory protection. P301 + P310 + P330 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. Rinse mouth. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/ doctor. P314 Get medical advice/ attention if you feel unwell. P362 Take off contaminated clothing and wash before reuse. P403 + P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
- none
2.1 Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) Acute toxicity, Oral (Category 3), H301 Acute toxicity, Inhalation (Category 2), H330 Acute toxicity, Dermal (Category 3), H311 Specific target organ toxicity - repeated exposure, Oral (Category 1), H372 For the full text of the H-Statements mentioned in this Section, see Section 16.